Open Access

Does Japanese encephalitis virus share the same cellular receptor with other mosquito-borne flaviviruses on the C6/36 mosquito cells?

  • Junping Ren1,
  • Tianbing Ding1,
  • Wei Zhang1,
  • Jianhua Song1 and
  • Wenyu Ma1Email author
Contributed equally
Virology Journal20074:83

DOI: 10.1186/1743-422X-4-83

Received: 11 June 2007

Accepted: 06 September 2007

Published: 06 September 2007

Abstract

Japanese encephalitis virus (JEV) is a member of mosquito-borne Flaviviridae. To date, the mechanisms of the early events of JEV infection remain poorly understood, and the cellular receptors are unidentified. There are evidences that the structure of the virus attachment proteins (VAP), envelope glycoprotein of mosquito-borne flaviviruses is very similar, and the vector-virus interaction of mosquito-borne flaviviruses is also very similar. Based on the studies previously demonstrated that the similar molecules present on the mosquito cells involved in the uptake process of JEV, West Nile virus (WNV) and Dengue virus (DV), it is proposed that the same receptor molecules for mosquito-borne flaviviruses (JEV, WNV and DV) may present on the surface of C6/36 mosquito cells. By co-immunoprecipitation assay, we investigated a 74-KDa protein on the C6/36 cells binds JEV, and the mass spectrometry results indicated it may be heat shock cognate protein 70(HSC70) from Aedes aegypti. Based upon some other viruses use of heat shock protein 70 (HSP70) family proteins as cell receptors, its possible HSC70's involvement in the fusion of the JEV E protein with the C6/36 cells membrane, and known form of cation channels in the interaction of HSC70 with the lipid bilayer, it will further be proposed that HSC70 as a penetration receptor mediates JEV entry into C6/36 cells.

1 Background

Japanese Encephalitis Virus (JEV) is an enveloped positive single stranded RNA virus belonging to genus Flavivirus in the family Flaviviridae. It is the most common agent of viral encephalitis, causing an estimated 50,000 cases annually, of which 15,000 will die and up to 50% of survivors are left with severe residual neurological complications [1, 2]. Most cases occur in southern and eastern Asia, but the geographical area affected by JEV is expanding. Outbreaks have been reported in Saipan islands, Torres Straits islands and on Australia mainland in recent years [35]. Cases have also occurred among travelers and US servicemen to Asia [6, 7].

The first step in virus infection requires interaction between the virus attachment proteins (VAP) and cellular receptors. The interaction of VAP and its cellular receptors is known to contribute to host range, tissue tropism and viral pathogenesis. The characteristic and function of virus receptor, once ascertained, may ultimately lead to the production of effective antiviral agents. But what are the cellular receptors for JEV? How the cellular receptors for JEV mediate JEV entry into the host cells?

To look for the answers to these questions, the authors made a detailed analysis on the JEV receptors, based upon previous flaviviruses receptor research results on Dengue virus (DV) and West Nile virus (WNV). By analyzing and summarizing the known characteristics of flaviviruses receptors on mosquito cells, we raised a hypothesis stating that a 74-KDa heat shock cognate protein 70(HSC70) may act as a penetration receptor for JEV on mosquito cells.

2 Discussion

2.1 The same receptor molecule(s) for mosquito-borne flaviviruses (JEV, WNV and DV) might present on the surface of mosquito cells

The classic notion of a virus binding to a single receptor to enter cells is being overtaken by the more complex conception. One of the complex concepts is that a virus particle can use multiple (individual) receptors during cell entry. Several viruses use at least two different receptors to interact with their host cells: (i) the binding receptors, which in general allow the virus particle to rapidly attach to the cell surface, and (ii) receptors that are used by the virus after binding to the cell, which are referred to using different terminology, such as post-binding, post-attachment, entry, fusion, internalization, secondary or co-receptors, depending on the function that they are known or proposed to play during the process of virus infection. In some instances, such as in the case of human immunodeficiency virus-1 (HIV-1), herpes simplex virus 1 and 2, adenovirus and measles virus [812], the multiple interactions that take place between the virus and cell surface molecules have been proposed to occur in a sequential manner. A prominent example of a dual receptor requirement occurs with HIV-1 binding. HIV-1 uses CD4 to bind the cell surface and chemokine so-called co-receptors, such as CXCR4 and CCR5, to facilitate the conformational alterations in envelope glycoproteins that culminate in fusion of the viral envelope and cell membrane.

Another complex concept is that very different viruses may use identical receptors. Although in most cases individual viruses have their own distinct receptors, in some cases the same receptor can be used by quite different viruses. Perhaps the best studied example of this is the coxsackie-adenovirus receptor or CAR [13]. CAR is a member of the immunoglobulin superfamily and mediates both attachment and entry of these two viruses. Another example is the integrins, that have been identified as attachment and entry receptors for several viruses[14], including reovirus (β1 integrins), echovirus (α2β1), foot-and-mouth disease virus (αvβ1, αvβ3, and αvβ6), hantaviruses NY-1 and Sin Nombre virus (β3 integrins), Kaposi sarcoma herpesvirus (α3β1), rotavirus (α2β1, αvβ3, αxβ2, and α4β3) and cytomegalovirus (α2β1, α6β1, and αvβ3). Integrins are a family of cell surface receptors that consist of α and β subunits. Integrins mediate cellular adhesion to the extracellular matrix (ECM), regulate cellular trafficking, and transducer both outside-in and inside-out signaling events.

Flaviviruses package their positive-strand RNA genome into particles consisting of a rigid outer protein shell and an underlying lipid membrane. The major envelope glycoprotein, E, and a small membrane protein, M, form the outer shell. As the principal envelope component, E is responsible for receptor binding and membrane fusion. Flavivirus E proteins belong to the structurally conserved "class II" fusion proteins, which are also found in alphaviruses. Crystal structures of four class II fusion proteins – Tick-borne encephalitis virus (TBEV) E [15, 16], Dengue virus (DV) E [1719], Semliki Forest virus (SFV) E1 [20, 21], and West Nile virus (WNV) E [22, 23] – before and after their fusogenic conformational rearrangements provide us with a detailed molecular picture of the fusion mechanism of these viruses. Based on the work of the above, it has been demonstrated that the E protein of the mature flaviviruses forms homodimers in an anti-parallel manner (head-to-tail orientation). Each monomer is folded into three distinct domains (Fig 1A and 1B), namely domain I (DI) – the central N-terminal domain; domain II (DII) – the dimerization domain; and domain III (DIII) – the immunoglobulin (Ig)-like domain. DIII of E protein consists of 100 amino acids (residues 303–395) of the C-terminal. This domain has been suggested to be the receptor recognition and binding domain due to a number of reasons. The Ig-like fold present in the DIII protein is commonly associated with structures that have an adhesion function. This domain extends perpendicularly to the surface of the virus with a tip projecting further from the virion surface than any part of the E protein. In addition, studies have demonstrated that both recombinant DIII proteins and antibodies generated against DIII of E protein of flaviviruses can inhibit entry of the flaviviruses into target cells [2426]. In addition, flaviviruses with mutations in DIII of the E protein show either attenuated virulence or the ability to escape immune neutralization [2730].
Figure 1

Summary of the Structural Organization and Different Conformations of the Flavivirus Envelope Protein E (obtained the kind permission from the copyright holder to reproduce figures that have previously been published on [51]). (A) Schematic top view of the organization of the sE protein dimer as present at the surface of mature virions, color-coded according to the three domains (DI, DII, and DIII). The fusion peptide (FP) is indicated in orange. (B) Crystal structure (top view) of the TBEV E ectodomain (termed "sE") dimer. (C) Schematic side view of the DV E dimer at the surface of mature virions, with the "stem" and TM C-terminal polypeptide segments (missing in the truncated sE form) indicated in green. The viral lipid bilayer is illustrated with lipids belonging to the outer and inner leaflets colored blue and pink, respectively. Cryo-electron microscopy 3D reconstructions have shown that the stem forms two α-helices (H1 and H2) lying on the viral membrane, followed by the two transmembrane (TM) segments. (D) Schematic representation illustrating the proposed organization of full-length DV E in its postfusion conformation. In this model, the α-helices of the stem interact with the body of the trimer, in the grooves between adjacent, parallel DIIs. The lipid bilayer as well as the stem and TM segments is drawn as in (C).

Neuroinvasiveness is a common feature of mosquito-borne flaviviruses infections where Culex mosquitoes are the predominant mosquito vector. In natural infection, mosquito-borne flaviviruses are first deposited in the mosquito vector and then in a human host bitten by the vector during a blood meal. Therefore, it is necessary to study receptors in mosquito cells to determine which binding proteins serve as true virus receptors. Several studies on the mosquito-borne flaviviruses, DV [3136], WNV [37], have been made significant progress in identifying a number of putative cellular receptors [glycolsaminoglycans, DC-SIGN, laminin receptor, glucose regulated protein 78 (GRP78), heat shock protein 90 (HSP90) and heat shock protein 70 (HSP70), αVβ3 integrin] in different mammalian cell types. However, the search for cellular receptor in mosquito cells has been less successful. A series of protein bands of different molecular masses on the mosquito cells (C6/36 cells) or mosquito tissues were observed to bind to DV [3842], WNV [43] and JEV [44].

Two glycoproteins of apparent molecular weights of 40- and 45-kDa expressed on the surface of C6/36 cells and mosquito tissues have been previously identified by del Angel and colleagues [3840] as potential Dengue virus serotype 4 (DV-4) receptor proteins. The 45-kDa protein has been shown to be widely expressed in mosquito tissues and antibodies against this protein specifically inhibit DV-4 infection. They demonstrated that periodate treatment of C6/36 cells protein extract modified the molecular weight of the 40- and 45-kDa glycoproteins to a 38-kDa protein, which was also able to bind DV-4. Therefore, the 40- and 45-kDa molecules are probably the glycosylated forms of the 38-kDa molecule. Sakoonwatanyoo and colleagues [41] identified a laminin-binding protein of 50-kDa on the surface of C6/36 cells as a candidate DV 2, 3, and 4 receptor protein. The authors have noticed that the marker used in their study gives higher calculated molecular weights than other markers. As such, they thought that the protein of 50-kDa identified by them and the 45-kDa protein identified by del Angel et al are probably the same protein. Another two proteins with molecular masses of 80- and 67-kDa on the midgut cells of Aedes aegypti and C6/36 cells have been recently identified as receptors for the four serotypes of DV [42]. Interestingly, Chu et al [43] identified proteins (55-kDa, 70-kDa, 95-kDa and 140-kDa) implicated in the binding and internalization of WNV, of which two (70- and 95-kDa) were proposed to be part of the receptor complex for mosquito-borne flaviviruses (WNV, JEV and DV) on C6/36 cells, as antibodies against these proteins blocked WNV, JEV and DV-2 entry into C6/36 cells. More recently, Boonsanay et al [44] identified several proteins on the surface of C6/36 cells binding to JEV, and predominant band was noted at 53-kDa, while other bands in the range of 150 to 200-kDa and minor bands of approximately 35-, 51- and 80-kDa were also observed. Soluble laminin produced a marginal, but dose-dependent inhibition of JEV infection, suggesting laminin role in virus-receptor interaction.

Collectively, on the surface of C6/36 cells or mosquito tissues the molecular masses approximately 38-, 40-, 45-, 50-kDa proteins have been identified as a candidate DV receptor protein, and are probably the same protein, laminin-binding protein. Another two proteins, molecular masses approximately 67 to 70-kDa and 80 to 95-kDa are probably a part of the receptor complex for mosquito-borne flaviviruses (JEV, WNV and DV). The evidences are listed as following: (i) the structure of VAP, envelope glycoprotein of mosquito-borne flaviviruses is very similar described as above; (ii) the vector-virus interaction of mosquito-borne flaviviruses is very similar. Based on the studies previously demonstrated that the similar molecules present on the mosquito cells involved in the uptake process of JEV, WNV and DV, it is proposed that the same receptor molecules for mosquito-borne flaviviruses (JEV, WNV and DV) may present on the surface of mosquito cells.

2.2 Heat shock cognate protein 70 (HSC70) may be a penetration receptor mediate JEV entry into C6/36 cells

To date, there has been little progress in identifying the nature of the molecules involved in the initial JEV entry, except that one report previously identified a 74-kDa protein expressed by Vero cells that may be involved in the uptake process [45], and another report identified several proteins on the surface of C6/36 cells binding to JEV [44]. However, the detailed characteristics and functioning of JEV receptor still remain a mystery.

We tried to investigate those proteins binding to JEV on the surface of C6/36 cells. Several positive proteins were observed in co-immunoprecipitation assay, and corresponding bands were then subject to mass spectrometry (data not published so far). The results indicated only a 74-kDa band may be HSC70 from Aedes aegypti. Amazingly, after transferred to nitrocellulose membrane, the 74-kDa protein from C6/36 cells was shown to bind only with HSC70 antibody but not with HSP70 antibody. Thus, we preferred that the 74-kDa HSC70 may be a cellular receptor for JEV. Further experiments directed to confirm the 74-KDa protein's activity as a putative cellular receptor for JEV are being performed in our laboratory. Such judgment we made is reasonably deducible due to the following reasons.

First, some other viruses, including human T lymphotropic virus type 1 (HTLV-1) [46], coxsackievirus A9 [47], rotavirus [48] and Dengue virus [35, 36] have been reported to use HSP70 family proteins as cell receptors. Specifically, GRP78 and HSP70 have been described as a member of a receptor complex on the mammalian cells for mosquito-borne flavivirus, Dengue virus. The HSP70 family is composed of four highly conserved proteins: HSP70, HSC70, GRP75 and GRP78. These proteins serve a variety of roles, such as acting as molecular chaperones facilitating the assembly of multi-protein complexes, participating in the translocation of polypeptides across cell membranes and to the nucleus, and aiding in the proper folding of nascent polypeptide chains. Virus proliferation depends on the successful recruitment of host cellular components for their own replication, protein synthesis, and virion assembly. HSP70 chaperones, as central component of the cellular chaperone network, are frequently recruited by viruses. Although HSP70 and HSC70 do not contain export signal peptide sequences, and more importantly depend in their chaperone function on repetitive cycles of ATP hydrolysis, they are found on the cell surface of a number of different cell types including tumor cells, virus infected cells, spermatogenic cells, epidermal cells, arterial smooth muscle cells, monocytes and B cells [49].

Second, HSC70 as chaperones might participate in the conformational changes of JEV envelope glycoprotein membrane fusion. Flaviviruses enter cells by receptor-mediate endocytosis, and the acidic pH in the endosome triggers the fusion of the viral envelope with the membrane of the target cells [50]. The crystal structures of the E ectodomain (termed "sE") were determined for four flaviviruses in both their prefusion and postfusion conformation [1523]. Flaviruses use only a single envelope glycoprotein (E) to mediate the membrane fusion during virus entry. Stiasny et al [51] recently reported a model to explain the conformational changes in E protein membrane fusion. In the prefusion form, as shown in Figure 1A and 1B, the three domains of sE are aligned along a rod-like molecule, with the C terminus and the fusion peptide (FP) lying at the two distal ends of the molecule. In full-length E, the sE segment connects to the C-terminal transmembrane (TM) segments via an element of about 50 amino acids (called "stem") that contains two α-helices, H1 and H2, which are peripherally attached to the viral envelope (Figure 1C). In the postfusion form, as shown in Figure 1D and 1E is converted into a more stable trimeric conformation. The structure of sE in the trimer shows that DIII is displaced from its original location and thus becomes positioned at the side of DI with its C terminus pointing toward the FP. This domain is the one that undergoes the most significant displacement in the dimer-to-trimer transition. In this scenario, it is tempting to speculate that a protein with chaperone activity, like HSC70, could have a pivotal role to help in these processes. By binding JEV E protein through DIII, it appears that HSC70 not only serves as an anchor on the cell membrane, but also modifies the conformational changes of dimer-to-trimer. This idea is consistent with the known functions of the HSC70 protein. For this reason, it is rational to hypothesize that HSC70 as a chaperone might participate in this proposed transition of JEV E protein.

Finally, HSC70 as a penetration receptor may mediate JEV entry into the C6/36 cells. To infect, a virus must first attach itself to the surface of a susceptible cell. The molecules to which viruses bind constitute a diverse collection of cellular proteins, carbohydrates, or lipids. Some of them merely serve as attachment factors that concentrate viruses on the cell's surface. Others are true receptors in that they not only bind viruses but are also responsible for guiding the bound viruses into endocytic pathways and for transmitting signals to the cytoplasm. These receptors can also serve as cues that induce conformational changes leading to membrane fusion and viral penetration [52].

All members of the HSP70 family contain three structural and functional domains [49]. The domain at the N terminus of the molecule (44-kDa) binds and hydrolyzes ATP. The subsequent region (18-kDa) participates in the interaction with target proteins (peptide binding domain). The C terminus of the molecule (10-kDa) seems to be involved in the association with co-chaperone molecules such as DnaJ. The interaction of HSP70s with peptides is modulated by the presence and hydrolysis of ATP. Thus, ATP is necessary for the recognition of the peptide, whereas hydrolysis of ATP to ADP increases the affinity for the peptide. The interaction of HSP70s with membranes may be necessary for the translocation of polypeptides across these lipid barriers. HSC70 is also known to interact with lipids, and it has been shown that this protein is able to form cation channels in acidic phospholipid membranes [53]. The HSC70 channel activity is ATP-dependent and is reversibly blocked by ADP. This channel has cationic selectivity. Perhaps the interaction of HSP70 with lipids is important in the processes of translocation and folding of membrane proteins. In addition, hydrophobic patches of HSC70, which are thought to be likely regions for interaction with membrane lipids, have been observed in the C-terminal of the ATP binding domain [54] and in the N-terminal of the peptide binding site [55], which may be involved in the interaction with the lipid bilayer.

Therefore, based upon HSC70's possible involvement in the fusion of the JEV E protein with the C6/36 cell membrane as described above, and its known form of cation channels in the interaction of HSC70 with the lipid bilayer, it is reasonably proposed that HSC70 as a penetration receptor mediate JEV entry into C6/36 cells.

3 Conclusion

Based upon several lines of evidence, it is reasonable to infer that mosquito-borne flaviviruses may share the same receptor molecule(s) on mosquito cells, because these viruses must replicate in mosquito cells first before injecting into host animals, including human. Compared with other mosquito-borne flaviviruses, Dengue is not a typical neuron-invasive virus, while JEV and WNV are characteristic with similar genome, neuron-invasive, and biological properties. Yet, it is also notable that more and more case reports recently indicated a increasing of Dengue infection manifested as encephalitis with unknown mechanism [56, 57]. However, the discrepancy of pathogenesis and clinical manifestations of these viruses strongly suggests that these viruses must have different receptor(s) and pathogenesis on human. Even so, identification and characterization of receptor on mosquito cells is the prologue to final elucidation of flavivirus pathogenesis on human. To confirm that HSC70 is a receptor for JEV on C6/36 mosquito cells, we are trying to do several experiments in our laboratory to: (i) make sure that JEV E protein interacts with HSC70 from C6/36 cell membranes by pull-down assay; (ii) test if antibodies against HSC70 block JEV infection, or inhibition of HSC70 expression by small RNA interference technique decrease JEV infection; and (iii) further define the specific interaction site(s) of HSC70 and JEV E protein.

Additionally, future research should define the role of HSC70 in JEV entry, identify any other co-receptors of JEV if existing, determine the route of JEV entry, and reveal the specific mechanism of JEV internalization. A combination of standard biochemical and molecular tools, together with the use of other technologies, such as RNA interference, as well as high-resolution structural cryo-electron microscopy and X-ray crystallography, will be required to gain insight into the elaborate mechanism employed by JEV to enter cells. The unveiled domain of JEV E protein in the conformational change interactions with cellular receptors could be a target of neutralizing antibodies or antiviral drugs. Such complexity pertaining to virus entry may make discovering treatments targeting this stage of infectious cycle more challenging, but the specificity involved in the processes, once ascertained, may ultimately lead to the production of effective antiviral agents or developments of new viral vaccines.

Notes

Declarations

Acknowledgements

The authors give a special thanks to Dr. Guangyu Li for encouragement and critical review of the manuscript. This work was supported by Natural Science Foundation of China (No.30600526, No.30400378, No. 30470091).

Authors’ Affiliations

(1)
Department of Microbiology, Fourth Military Medical University

References

  1. Tsai TF: New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13–15 October 1998. Vaccine 2000,18(Suppl 2):1-25.PubMedView ArticleGoogle Scholar
  2. Solomon T: Control of Japanese encephalitis – within our grasp? NEJM 2006,355(9):869-871.PubMedView ArticleGoogle Scholar
  3. Paul WS, Moore PS, Karabatsos N, Flood SP, Yamada S, Jackson T, Tsai TF: Outbreak of Japanese encephalitis on the island of Saipan. J Infect Dis 1993,167(5):1053-1058.PubMedView ArticleGoogle Scholar
  4. Hanna JN, Ritchie SA, Phillips DA, Shield J, Bailey MC, Mackenzie JS, Poidinger M, McCall BJ, Mills PJ: An outbreak of Japanese encephalitis in the Torres Strait Australia, 1995. Med J Austra 1996,165(5):256-260.Google Scholar
  5. Hanna JN, Ritchie SA, Phillips DA, Lee JM, Hills SL, van den Hurk AF, Pyke AT, Johansen CA, Mackenzie JS: Japanese encephalitis in north Queensland, Australia, 1998. Med J Aust 1999,170(11):533-536.PubMedGoogle Scholar
  6. Burdon JT, Stanley PJ, Lloyd G, Jones NC: A case of Japanese encephalitis. J Infect 1994,28(2):175-179.PubMedView ArticleGoogle Scholar
  7. Saito M, Sunagawa T, Makino Y, Tadano M, Hasegawa H, Kanemura K, Zamami Y, Killenbeck BJ, Fukunaga T: Three Japanese encephalitis cases in Okinawa, Japan, 1991. Southeast Asian. J Tropical Medicine Public Health 1999,30(2):277-279.Google Scholar
  8. Freed EO: HIV-1 and the host cell: an intimate association. Trends Microbiol 2004,12(4):170-177.PubMedView ArticleGoogle Scholar
  9. Spear PG, Longnecker R: Herpesvirus entry: an update. J Virol 2003,77(19):10179-10185.PubMedPubMed CentralView ArticleGoogle Scholar
  10. Bender FC, Whitbeck JC, de Leon MP, Lou H, Eisenberg RJ, Cohen GH: Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry. J Virol 2003,77(17):9542-9552.PubMedPubMed CentralView ArticleGoogle Scholar
  11. Wu E, Nemerow GR: Virus yoga: the role of flexibility in virus host cell recognition. Trends Microbiol 2004,12(4):162-169.PubMedView ArticleGoogle Scholar
  12. Oldstone MB, Homann D, Lewicki H, Stevenson D: One, two, or three step: measles virus receptor dance. Virology 2002,299(2):162-163.PubMedView ArticleGoogle Scholar
  13. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW: Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997,275(5304):1320-1323.PubMedView ArticleGoogle Scholar
  14. Maginnis MS, Forrest JC, Kopecky-Bromberg SA, Nemerow GR, Bergelson JM, Dermody TS: Beta1 integrin mediates internalization of mammalian reovirus. J Virol 2006,80(6):2760-2770.PubMedPubMed CentralView ArticleGoogle Scholar
  15. Rey FA, Heinz FX, Mandl C, Kunz C, Harrison SC: The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 1995,375(6529):291-298.PubMedView ArticleGoogle Scholar
  16. Heinz FX, Rey FA: Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J 2004,23(4):728-738.PubMedPubMed CentralView ArticleGoogle Scholar
  17. Modis Y, Ogata S, Clements D, Harrison SC: A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci USA 2003,100(12):6986-6991.PubMedPubMed CentralView ArticleGoogle Scholar
  18. Zhang W, Chipman PR, Corver J, Johnson PR, Zhang Y, Mukhopadhyay S, Baker TS, Strauss JH, Rossmann MG, Kuhn RJ: Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol 2003,10(11):907-912.PubMedPubMed CentralView ArticleGoogle Scholar
  19. Modis Y, Ogata S, Clements D, Harrison SC: Structure of the dengue virus envelope protein after membrane fusion. Nature 2004,427(6972):313-319.PubMedView ArticleGoogle Scholar
  20. Gibbons DL, Vaney MC, Roussel A, Vigouroux A, Reilly B, Lepault J, Kielian M, Rey FA: Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. Nature 2004,427(6972):320-325.PubMedView ArticleGoogle Scholar
  21. Lescar J, Roussel A, Wien MW, Navaza J, Fuller SD, Wengler G, Wengler G, Rey FA: The fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH. Cell 2001,105(1):137-148.PubMedView ArticleGoogle Scholar
  22. Kanai R, Kar K, Anthony K, Gould LH, Ledizet M, Fikrig E, Marasco WA, Koski RA, Modis Y: Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes. J Virol 2006,80(22):11000-11008.PubMedPubMed CentralView ArticleGoogle Scholar
  23. Nybakken GE, Nelson CA, Chen BR, Diamond MS, Fremont DH: Crystal structure of the West Nile virus envelope glycoprotein. J Virol 2006,80(23):11467-11474.PubMedPubMed CentralView ArticleGoogle Scholar
  24. Chu JJ, Rajamanonmani R, Li J, Bhuvanakantham R, Lescar J, Ng ML: Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein. J Gen Virol 2005,86(Pt2):405-412.PubMedView ArticleGoogle Scholar
  25. Hung JJ, Hsieh MT, Young MJ, Kao CL, King CC, Chang W: An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J Virol 2004,78(1):378-388.PubMedPubMed CentralView ArticleGoogle Scholar
  26. Chin JF, Chu JJ, Ng ML: The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry. Microbes and Infection 2007,9(1):1-6.PubMedView ArticleGoogle Scholar
  27. Lin CW, Wu SC: A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites. J Virol 2003,77(4):2600-2606.PubMedPubMed CentralView ArticleGoogle Scholar
  28. Mandl CW, Allison SL, Holzmann H, Meixner T, Heinz FX: Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site. J Virol 2000,74(20):9601-9609.PubMedPubMed CentralView ArticleGoogle Scholar
  29. Ni H, Ryman KD, Wang H, Saeed MF, Hull R, Wood D, Minor PD, Watowich SJ, Barrett AD: Interaction of yellow fever virus French neurotropic vaccine strain with monkey brain: characterization of monkey brain membrane receptor escape variants. J Virol 2000,74(6):2903-2906.PubMedPubMed CentralView ArticleGoogle Scholar
  30. Sanchez IJ, Ruiz BH: A single nucleotide change in the E protein gene of dengue virus 2 Mexican strain affects neurovirulence in mice. J Gen Virol 1996,77(Pt10):2541-2545.PubMedView ArticleGoogle Scholar
  31. Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, Marks RM: Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 1997,3(8):866-871.PubMedView ArticleGoogle Scholar
  32. Navarro-Sanchez E, Altmeyer R, Amara A, Schwartz O, Fieschi F, Virelizier JL, Arenzana-Seisdedos F, Desprès P: Dendriticcell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells bymosquito-cell-derived dengue viruses. EMBO Rep 2003,4(7):723-728.PubMedPubMed CentralView ArticleGoogle Scholar
  33. Tassaneetrithep B, Burgess TH, Granelli-Piperno A, Trumpfheller C, Finke J, Sun W, Eller MA, Pattanapanyasat K, Sarasombath S, Birx DL, Steinman RM, Schlesinger S, Marovich MA: DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 2003,197(7):823-829.PubMedPubMed CentralView ArticleGoogle Scholar
  34. Thepparit C, Smith DR: Serotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high affinity laminin receptor as a dengue virus serotype 1 receptor. J Virol 2004,78(22):12647-12656.PubMedPubMed CentralView ArticleGoogle Scholar
  35. Jindadamrongwech S, Thepparit C, Smith DR: Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. Arch Virol 2004,149(5):915-927.PubMedView ArticleGoogle Scholar
  36. Reyes-Del Valle J, Chavez-Salinas S, Medina F, Del Angel RM: Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J Virol 2005,79(8):4557-4567.PubMedPubMed CentralView ArticleGoogle Scholar
  37. Chu JJ, Ng ML: Characterization of a 105-kDa plasma membrane associated glycoprotein that is involved in West Nile virus binding and infection. Virology 2003,312(2):458-469.PubMedView ArticleGoogle Scholar
  38. Salas-Benito JS, Del Angel RM: Identification of two surface proteins from C6/36 cells that bind dengue type 4 virus. J Virol 1997,71(10):7246-7252.PubMedPubMed CentralGoogle Scholar
  39. Yazi Mendoza M, Salas-Benito JS, Lanz-Mendoza H, Hernandez-Martinez S, Del Angel RM: A putative receptor for dengue virus in mosquito tissues: localization of a 45-kDa glycoprotein. Am J Trop Med Hyg 2002,67(1):76-84.PubMedGoogle Scholar
  40. Reyes-del Valle J, Del Angel RM: Isolation of putative dengue virus receptor molecules by affinity chromatography using a recombinant E protein ligand. J Virol Methods 2004,116(1):95-102.PubMedView ArticleGoogle Scholar
  41. Sakoonwatanyoo P, Boonsanay V, Smith DR: Growth and production of the dengue virus in C6/36 cells and identification of a laminin-binding protein as a candidate serotype 3 and 4 receptor protein. Intervirology 2006,49(3):161-172.PubMedView ArticleGoogle Scholar
  42. Mercado-Curiel RF, Esquinca-Aviles HA, Tovar R, Díaz-Badillo A, Camacho-Nuez M, Muñoz Mde L: The four serotypes of dengue recognize the same putative receptors in Aedes aegypti midgut and Ae. albopictus cells. BMC Microbiol 2006, 6: 85-94.PubMedPubMed CentralView ArticleGoogle Scholar
  43. Chu JJ, Leong PW, Ng ML: Characterization of plasma membrane-associated proteins from Aedes albopictus mosquito (C6/36) cells that mediate West Nile virus binding and infection. Virology 2005,339(2):249-260.PubMedView ArticleGoogle Scholar
  44. Boonsanay V, Smith DR: Entry into and production of the Japanese encephalitis virus from C6/36 cells. Intervirology 2007,50(2):85-92.PubMedView ArticleGoogle Scholar
  45. Kimura T, Kimura-Kuroda J, Nagashima K, Yasui K: Analysis of virus-cell binding characteristics on the determination of Japanese encephalitis virus susceptibility. Arch Virol 1994,139(3–4):239-251.PubMedView ArticleGoogle Scholar
  46. Sagara Y, Ishida C, Inoue Y, Shiraki H, Maeda Y: 71-kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1. J Virol 1998,72(1):535-541.PubMedPubMed CentralGoogle Scholar
  47. Triantafilou K, Fradelizi D, Wilson K, Triantafilou M: GRP78, a coreceptor for coxsackievirus A9, interacts with major histocompatibility complex class I molecules which mediate virus internalization. J Virol 2002,76(2):633-643.PubMedPubMed CentralView ArticleGoogle Scholar
  48. Guerrero CA, Bouyssounade D, Zarate S, Isa P, López T, Espinosa R, Romero P, Méndez E, López S, Arias CF: Heat shock cognate protein 70 is involved in rotavirus cell entry. J Virol 2002,76(8):4096-4102.PubMedPubMed CentralView ArticleGoogle Scholar
  49. Mayer MP: Recruitment of Hsp70 chaperones: a crucial part of viral survival strategies. Rev Physiol Biochem Pharmacol 2005, 153: 1-46.PubMedGoogle Scholar
  50. Heinz FX, Allison SL: The machinery for flavivirus fusion with host cell membrane. Curr Opin Microbiol 2001,4(4):450-455.PubMedView ArticleGoogle Scholar
  51. Stiasny K, Kössl C, Lepault J, Rey FA, Heinz FX: Characterization of a structural intermediate of flavivirus membrane fusion. PLoS Pathog 2007,3(2):191-199.View ArticleGoogle Scholar
  52. Smith AE, Helenius A: How viruses enter animal cells. Science 2004,304(4):137-242.Google Scholar
  53. Arispe N, De Maio A: ATP and ADP modulate a cation channel formed by Hsc70 in acid phospholipid membranes. J Biol Chem 2000,275(40):30839-30843.PubMedView ArticleGoogle Scholar
  54. Flaherty KM, DeLuca-Flaherty C, McKay DB: Three-dimensional structure of the ATPase fragment of a 70 K heat-shock cognate protein. Nature 1990,346(6285):623-628.PubMedView ArticleGoogle Scholar
  55. Morshauser RC, Hu W, Wang H, Pang Y, Flynn GC, Zuiderweg ER: High-resolution solution structure of the 18 kDa substrate-binding domain of the mammalian chaperone protein HSC70. J Mol Biol 1999,289(5):1387-403.PubMedView ArticleGoogle Scholar
  56. Solomon T, Dung NM, Vaughn DW, Kneen R, Thao LT, Raengsakulrach B, Loan HT, Day NP, Farrar J, Myint KS, Warrell MJ, James WS, Nisalak A, White NJ: Neurological manifestations of dengue infection. Lancet 2000,355(3):1053-1059.PubMedView ArticleGoogle Scholar
  57. Misra UK, Kalita J, Syam UK, Dhole TN: Neurological manifestations of dengue virus infection. J Neurol Sci 2006,244(1–2):117-22.PubMedView ArticleGoogle Scholar

Copyright

© Ren et al; licensee BioMed Central Ltd. 2007

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement